When is belzutifan the right option for von Hippel-Lindau disease-associated hemangioblastomas?—a critical review of LITESPARK-004 results
@article{TCR100056, author = {Ugur Sener and Taylor Galloway}, title = {When is belzutifan the right option for von Hippel-Lindau disease-associated hemangioblastomas?—a critical review of LITESPARK-004 results}, journal = {Translational Cancer Research}, volume = {0}, number = {0}, year = {2025}, keywords = {}, abstract = {}, issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/100056} }